Pfizer, Merck KGaA sales and marketing update

Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that added benefit of Xalkori crizotinib from Pfizer to treat first-line advanced bronchial carcinom...